Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.

Authors :: Rouzaud F
Robledo J
Source :: Indian journal of medical microbiology [Indian J Med Microbiol] 2010 Oct-Dec; Vol. 28 (4), pp. 412-3.
Publication Year :: 2010

Subjects :: Culture Media chemistry
Humans
Isoniazid pharmacology
Isoniazid therapeutic use
Microbial Sensitivity Tests economics
Microbial Sensitivity Tests methods
Rifampin pharmacology
Rifampin therapeutic use
Tuberculosis drug therapy
Tuberculosis economics
Tuberculosis, Multidrug-Resistant diagnosis
Tuberculosis, Multidrug-Resistant drug therapy
Tuberculosis, Multidrug-Resistant economics
Antitubercular Agents pharmacology
Culture Media economics
Drug Resistance, Bacterial
Mycobacterium tuberculosis drug effects
Tuberculosis diagnosis

Full Text Access

Tools